November 14, 2017
New York, NY
Panelist : Norman Shelby
Real Endpoints LLC
Immuno-oncology treatments have provided renewed hope to cancer patients. Combination treatments bring the promise of increased efficacy with manageable side effects. Come hear from experts about what the future may bring.
Moderator Norman Selby, Board of Trustees at Memorial Sloan Kettering, Executive Chairman of RealEndpoints and PAIGE.AI, former Senior Partner at McKinsey.
Panelists: Sophie Opdyke, VP, Immuno-Oncology Lead, Global Commercial Development at Pfizer Umer Raffat, Managing Director at Evercore ISI Peter Bach, Director, Center for Health Policy and Outcomes at MSK.
view event >
April 29, 2018 - May 2, 2018
Table 10| The Palazzo| Las Vegas, NV
Speaker and Host: Roger Longman
Attendee: Real Endpoints Team
Asembia’s Annual Specialty Pharmacy Summit will return to Wynn & Encore Las Vegas from April 29 through May 2, 2018. The Summit welcomes thousands of industry executives and professionals. Agenda highlights include business workshops, educational seminars, exhibits, and live continuing education credits, along with numerous networking and social events.
April 24, 2018
Boston, MA
Panelist: Michael Sherman, Chief Medical Officer, Harvard Pilgrim
Panelist: C. Bernie Good, Senior Medical Director, Center for Value-Based Pharmacy Initiatives, UPMC
Moderator: Roger Longman, CEO, Real Endpoints
(Invitation only)
March 21, 2018
New York, NY
Keynote Speaker: Roger Longman
Real Endpoints LLC
The BCUSA showcases biotechs with advanced therapeutics and brings them together with pharma partnering executives and institutional investors, bankers and advisers.
February 27, 2018 - February 28, 2018
Philadelphia, PA
Attendee: Real Endpoints Team
Over 700 leaders in Patient Access, Brand Management, Reimbursement and Specialty Distribution across the industry have benefited from CBI’s Hub and SPP Model Optimization conference series.
January 17, 2018 3pm EST
Webinar
Speaker: Dan Danielson, Pharmacy Manager, Premera BlueCross
Speaker: Dan Olendorf, Chief Scientific Officer, Institute for Clinical & Economic Review (ICER)
Moderator: Jane Barlow, EVP & Chief Clinical Officer, Real Endpoints
Adventures in over-, under-, and correctly estimating drug costs…and defining what’s worth the extra money.
November 14, 2017
New York, NY
Panelist : Norman Shelby
Real Endpoints LLC
Immuno-oncology treatments have provided renewed hope to cancer patients. Combination treatments bring the promise of increased efficacy with manageable side effects.
Manager
Payer & Channel Insights, Marketing Analytics & Business Insights